🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 11 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 29/12/2015 | 66,96 | 70,49 | 66,64 | 69,15 | +3,99% | 5,76% | 477.854 |
| 28/12/2015 | 67,06 | 67,34 | 65,71 | 66,49 | -1,63% | 2,43% | 245.419 |
| 24/12/2015 | 66,84 | 68,08 | 66,81 | 67,60 | +0,91% | 1,91% | 115.737 |
| 23/12/2015 | 67,62 | 67,72 | 66,56 | 66,99 | +0,05% | 1,72% | 251.190 |
| 22/12/2015 | 67,89 | 68,02 | 65,81 | 66,96 | -0,51% | 3,24% | 234.679 |
| 21/12/2015 | 68,83 | 69,54 | 66,63 | 67,30 | -1,96% | 4,23% | 423.994 |
| 18/12/2015 | 69,65 | 69,65 | 66,92 | 68,65 | -1,62% | 3,91% | 1.097.574 |
| 17/12/2015 | 69,80 | 71,12 | 68,92 | 69,78 | +0,42% | 3,15% | 651.940 |
| 16/12/2015 | 66,97 | 69,76 | 66,40 | 69,48 | +4,91% | 5,01% | 595.515 |
| 15/12/2015 | 65,95 | 67,37 | 65,13 | 66,23 | +1,85% | 3,41% | 510.395 |
| 14/12/2015 | 64,39 | 65,34 | 62,69 | 65,03 | +1,15% | 4,11% | 362.599 |
| 11/12/2015 | 67,05 | 68,01 | 64,07 | 64,29 | -5,45% | 5,88% | 517.288 |
| 10/12/2015 | 66,82 | 68,62 | 66,82 | 67,99 | +1,65% | 2,70% | 357.950 |
| 09/12/2015 | 68,05 | 68,05 | 66,45 | 66,89 | -1,94% | 2,35% | 494.526 |
| 08/12/2015 | 64,96 | 68,62 | 64,70 | 68,21 | +3,56% | 6,02% | 472.244 |
| 07/12/2015 | 66,66 | 67,34 | 65,04 | 65,86 | -1,50% | 3,45% | 390.651 |
| 04/12/2015 | 65,81 | 67,28 | 65,12 | 66,87 | +2,29% | 3,29% | 322.524 |
| 03/12/2015 | 67,42 | 67,53 | 64,24 | 65,37 | -2,27% | 4,89% | 380.552 |
| 02/12/2015 | 67,79 | 68,58 | 66,66 | 66,89 | -1,19% | 2,84% | 437.779 |
| 01/12/2015 | 67,37 | 67,97 | 65,45 | 67,69 | +1,34% | 3,73% | 791.882 |
| 30/11/2015 | 65,78 | 67,24 | 65,18 | 66,80 | +1,05% | 3,13% | 576.599 |
| 27/11/2015 | 65,58 | 66,49 | 64,96 | 66,11 | +1,29% | 2,33% | 128.721 |
| 25/11/2015 | 63,78 | 66,16 | 63,78 | 65,27 | +2,27% | 3,73% | 544.539 |
| 24/11/2015 | 64,07 | 64,73 | 62,51 | 63,82 | -0,93% | 3,47% | 486.991 |
| 23/11/2015 | 64,25 | 66,15 | 63,46 | 64,42 | +0,25% | 4,19% | 642.803 |
| 20/11/2015 | 63,63 | 65,50 | 63,57 | 64,25 | +0,83% | 3,02% | 407.643 |
| 19/11/2015 | 66,63 | 66,63 | 62,40 | 63,72 | -3,89% | 6,35% | 655.306 |
| 18/11/2015 | 63,36 | 66,49 | 63,14 | 66,30 | +5,41% | 5,29% | 766.715 |
| 17/11/2015 | 62,75 | 63,94 | 61,73 | 62,90 | +1,03% | 3,52% | 421.749 |
| 16/11/2015 | 61,24 | 62,68 | 60,38 | 62,26 | +1,27% | 3,76% | 643.284 |